Hoshino J, Yamagata K, Nishi S, Nakai S, Masakane I, Iseki K, et al. Carpal tunnel surgery as proxy for dialysis-related amyloidosis: results from the Japanese society for dialysis therapy. Am J Nephrol. 2014;39:449–58.
Article CAS PubMed Google Scholar
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant. 2008;23:2337–43.
Panichi V, Paoletti S, Consani C. Inflammatory pattern in hemodiafiltration. Contrib Nephrol. 2008;161:185–90.
Susantitaphong P, Siribamrungwong M, Jaber BL. Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant. 2013;28:2859–74.
Article CAS PubMed Google Scholar
Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis. 2014;63:954–67.
Wang AY, Ninomiya T, Al-Kahwa A, Perkovic V, Gallagher MP, Hawley C, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014;63:968–78.
Nitta K, Abe M, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes. Ren Replace Ther. 2020;6:51.
Tsuchida K, Minakuchi J. Clinical benefits of predilution on-line hemodiafiltration. Blood Purif. 2013;35(Suppl 1):18–22.
Masakane I, Kikuchi K, Kawanishi H. Evidence for the clinical advantages of predilution on-line hemodiafiltration. Contrib Nephrol. 2017;189:17–23.
Kawanishi H. Development of online hemodiafiltration in Japan. Ren Replace Ther. 2021;7:51.
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24:487–97.
Article PubMed PubMed Central Google Scholar
Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23:1087–96.
Article CAS PubMed PubMed Central Google Scholar
Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013;28:192–202.
Sakurai K, Saito T, Yamauchi F, Asahi D, Hosoya H. Comparison of the effects of predilution and postdilution hemodiafiltration on neutrophils, lymphocytes and platelets. J Artif Organs. 2013;16:316–21.
Article CAS PubMed Google Scholar
Sakurai K, Saito T, Yamauchi F, Hosoya HH, Kurihara Y, Yoshida K, et al. Comparison of the effects of pre-dilution and post-dilution on-line hemodiafiltration on inflammatory markers, lymphocytes and platelets. Nephrol Dial Transplant. 2018;33:186–9.
Mineshima M, Kawanishi H, Ase T, Kawasaki T, Tomo T, Nakamoto H. 2016 update Japanese Society for Dialysis Therapy Standard of fluids for hemodialysis and related therapies. Ren Replace Ther. 2018;4:15.
Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.
Yamashita AC. The clear space index. Contrib Nephrol. 2017;189:197–203.
Gelman A, Hill J, Yajima M. Why we (usually) don’t have to worry about multiple comparisons. J Res Educ Eff. 2012;5:189–211.
Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 2004;66:2047–53.
Elder SJ, Pisoni RL, Akizawa T, Fissell R, Andreucci VE, Fukuhara S, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008;23:998–1004.
Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69:1626–32.
Article CAS PubMed Google Scholar
Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66:1212–20.
Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, et al. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2014;64:86–94.
Article PubMed PubMed Central Google Scholar
Maduell F, Ojeda R, Arias-Guillen M, Bazan G, Vera M, Fontsere N, et al. Assessment of dialyzer surface in online hemodiafiltration; objective choice of dialyzer surface area. Nefrologia. 2015;35:280–6.
Sakurai K. Biomarkers for evaluation of clinical outcomes of hemodiafiltration. Blood Purif. 2013;35(Suppl 1):64–8.
Article CAS PubMed Google Scholar
Maduell F, Arias-Guillen M, Fontsere N, Ojeda R, Rico N, Vera M, et al. Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies. Blood Purif. 2014;37:125–30.
Article CAS PubMed Google Scholar
Grosjean F, Esposito P, Maccarrone R, Libetta C, Dal Canton A, Rampino T. RBP4: a culprit for insulin resistance in end stage renal disease that can be cleared by hemodiafiltration. Biomed Res Int. 2017; p. 7270595. https://doi.org/10.1155/2017/7270595.
Akerstrom B, Maghzal GJ, Winterbourn CC, Kettle AJ. The lipocalin alpha1-microglobulin has radical scavenging activity. J Biol Chem. 2007;282:31493–503.
Rutardottir S, Karnaukhova E, Nantasenamat C, Songtawee N, Prachayasittikul V, Rajabi M, et al. Corrigendum to “Structural and biochemical characterization of two heme binding sites on alpha1-microglobulin using site directed mutagenesis and molecular simulation” [BBAPAP 1864/1 (2016) Page 29 to 41]. Biochim Biophys Acta Proteins Proteom. 2020;1868: 140394.
Article CAS PubMed Google Scholar
Kristiansson A, Bergwik J, Alattar AG, Flygare J, Gram M, Hansson SR, et al. Human radical scavenger alpha1-microglobulin protects against hemolysis in vitro and alpha1-microglobulin knockout mice exhibit a macrocytic anemia phenotype. Free Radic Biol Med. 2021;162:149–59.
Article CAS PubMed Google Scholar
Kurihara Y, Hosoya H, Kishihara R, Yoshinaga M, Iwadate Y, Yamauchi F, et al. Comparison of the effects of pre-dilution and post-dilution online hemodiafiltration on the levels of inflammatory markers, lymphocytes, and platelets. J Artif Organs. 2022;25:59–65.
Article CAS PubMed Google Scholar
Okada K, Michiwaki H, Mori H, Tashiro M, Inoue T, Shima H, et al. Removal performance of pre- and post-dilution online hemodiafiltration using identical hemodiafilters in the same patients. J Artif Organs 2022 [ahead of print].
Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006;17:546–55.
Article CAS PubMed Google Scholar
Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, Maeno Y, Yamakawa T, et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant. 2009;24:571–7.
Article CAS PubMed Google Scholar
Watanabe Y, Kawanishi H, Suzuki K, Nakai S, Tsuchida K, Tabei K, et al. Japanese society for dialysis therapy clinical guideline for “Maintenance hemodialysis: hemodialysis prescriptions.” Ther Apher Dial. 2015;19 Suppl 1:67–92.
Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial. 2009;13:457–504.
Sakurai K, Hosoya H, Kurihara Y, Yamauchi F, Suzuki A, Kurosawa K, et al. Evaluation of low-volume post-dilution online hemodiafiltration with Japanese high-performance hemodiafilters. J Artif Organs. 2020;23:234–9.
Article CAS PubMed PubMed Central Google Scholar
Albalate Ramon M, Martinez Miguel P, Bohorquez L, de Sequera P, Bouarich H, Perez-Garcia R, et al. Asymmetric cellulose triacetate is a safe and effective alternative for online haemodiafiltration. Nefrologia (Engl Ed). 2018;38:315–20.
留言 (0)